**Core Concept**
The Nitroblue tetrazolium (NBT) test is a diagnostic tool used to assess the functional activity of neutrophil oxidative metabolism, specifically the production of superoxide anions by the enzyme NADPH oxidase.

**Why the Correct Answer is Right**
The NBT test is based on the principle that neutrophils with normal NADPH oxidase activity can reduce the yellow tetrazolium salt (NBT) to a blue formazan product, which is then visible under a microscope. This reaction is indicative of the neutrophil's ability to produce superoxide anions, which are crucial for the killing of ingested microorganisms. The NBT test is commonly used to diagnose chronic granulomatous disease (CGD), a genetic disorder characterized by the absence or deficiency of NADPH oxidase activity.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the NBT test is not used for diagnosing autoimmune disorders such as lupus.
**Option B:** This option is incorrect because the test is not used for detecting fungal infections like candidiasis.
**Option C:** This option is incorrect because the NBT test is not used for screening for HIV infection.

**Clinical Pearl / High-Yield Fact**
Chronic granulomatous disease (CGD) is an inherited disorder that affects approximately 1 in 200,000 individuals worldwide, and the NBT test is a crucial diagnostic tool for identifying this condition.

**Correct Answer:** Not Provided.